CAN B CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0258 USD | -9.47% |
|
-19.38% | -2.64% |
| 15/04 | Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Can B Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 6.69M 558M | Sales 2023 | 2.16M 180M | Capitalization | 830K 69.28M |
|---|---|---|---|---|---|
| Net income 2022 | -14M -1.17B | Net income 2023 | -9M -751M | EV / Sales 2022 | 2.25 x |
| Net Debt 2022 | 9.26M 773M | Net Debt 2023 | 9.15M 763M | EV / Sales 2023 | 4.63 x |
| P/E ratio 2022 |
-0.31
x | P/E ratio 2023 |
-0.03
x | Employees | 12 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 94.43% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -9.47% | ||
| 1 week | -19.38% | ||
| Current month | -32.28% | ||
| 1 month | -3.37% | ||
| 3 months | -49.31% | ||
| 6 months | -42.67% | ||
| Current year | -2.64% |
1 week
0.03
0.03
1 month
0.030.08
Current year
0.010.17
1 year
0.010.89
3 years
0.0114.70
5 years
0.01247.50
10 years
0.011 800.02
| Managers | Title | Age | Since |
|---|---|---|---|
Marco Alfonsi
CEO | Chief Executive Officer | 64 | 01/15/01 |
Stanley Teeple
DFI | Director of Finance/CFO | 76 | 01/18/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Frederick Boyer
BRD | Director/Board Member | 56 | 09/19/09 |
Stanley Teeple
DFI | Director of Finance/CFO | 76 | 01/18/01 |
Marco Alfonsi
CEO | Chief Executive Officer | 64 | 01/15/01 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 0.0258 | -9.47% | 407,010 |
| 13/24/13 | 0.0285 | +5.56% | 227,165 |
| 10/24/10 | 0.027 | +1.89% | 222,550 |
| 09/24/09 | 0.0265 | -7.02% | 109,656 |
| 08/24/08 | 0.0285 | -10.94% | 61,276 |
End-of-day quote OTC Markets, May 14, 2024
More quotes
Can B Corp. is a health and wellness company. The Company is engaged in developing, manufacturing, and selling products containing cannabinoids derived from hemp biomass and the licensing of durable medical devices. Its products include oils, creams, moisturizers, isolates, gel caps, spa products, and concentrates and lifestyle products. It develops its own line of proprietary products, as well as seeks synergistic value through acquisitions in the hemp industry. Its Duramed Division provides a sam Pro 2.0 medical device to patients through a doctor program whereby the physician evaluates the patients' needs for medical necessity, and if determined that the device use would be beneficial, writes a prescription for the patient, who signs a rental form, for a 35-day cycle for the unit, that is submitted to Duramed who bills the appropriate insurance company. The Company is also focuses on protecting and commercializing the cannabis patents covering liquid formulations of cannabis.
Sector
Food Retail & Distribution
Calendar
28/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -2.64% | 1.41M | |
| +13.73% | 482B | |
| +20.33% | 39.89B | |
| +3.31% | 37.79B | |
| +20.48% | 34.84B | |
| +11.94% | 30.02B | |
| +6.82% | 27.52B | |
| -15.83% | 25.17B | |
| +15.56% | 18.68B | |
| +3.87% | 18.17B |
- Stock Market
- Equities
- CANB Stock